Nahed Baddour

661 total citations
38 papers, 518 citations indexed

About

Nahed Baddour is a scholar working on Epidemiology, Hepatology and Molecular Biology. According to data from OpenAlex, Nahed Baddour has authored 38 papers receiving a total of 518 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Epidemiology, 15 papers in Hepatology and 6 papers in Molecular Biology. Recurrent topics in Nahed Baddour's work include Liver Disease Diagnosis and Treatment (10 papers), Hepatitis C virus research (6 papers) and Hepatitis B Virus Studies (5 papers). Nahed Baddour is often cited by papers focused on Liver Disease Diagnosis and Treatment (10 papers), Hepatitis C virus research (6 papers) and Hepatitis B Virus Studies (5 papers). Nahed Baddour collaborates with scholars based in Egypt, United States and United Kingdom. Nahed Baddour's co-authors include Maha M. Eissa, Mervat Z. El‐Azzouni, Ahmed Adam, A. Meguid El Nahas, Eglal I. Amer, David H. Van Thiel, Timothy S. Johnson, Nicholas J. Skill, Martin Griffin and Eiman Aleem and has published in prestigious journals such as SHILAP Revista de lepidopterología, Kidney International and Journal of the American Society of Nephrology.

In The Last Decade

Nahed Baddour

37 papers receiving 511 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Nahed Baddour Egypt 12 119 113 112 100 86 38 518
Ting Song China 13 106 0.9× 232 2.1× 144 1.3× 35 0.3× 56 0.7× 29 732
Lesley Maxwell Australia 12 74 0.6× 84 0.7× 16 0.1× 28 0.3× 127 1.5× 25 656
Vedat Göral Türkiye 14 106 0.9× 196 1.7× 152 1.4× 24 0.2× 224 2.6× 41 675
Ruiqing Zhang China 11 65 0.5× 224 2.0× 71 0.6× 34 0.3× 216 2.5× 50 861
Silvia Benali Italy 14 131 1.1× 45 0.4× 10 0.1× 32 0.3× 43 0.5× 29 422
Hossain M. Golbar Japan 14 45 0.4× 112 1.0× 167 1.5× 15 0.1× 74 0.9× 32 502
Kaori Mukai Japan 14 109 0.9× 45 0.4× 35 0.3× 79 0.8× 203 2.4× 54 1.1k
Xiaoqun Zheng China 14 66 0.6× 160 1.4× 20 0.2× 16 0.2× 60 0.7× 68 705
Seiji Arihiro Japan 16 102 0.9× 151 1.3× 15 0.1× 56 0.6× 161 1.9× 50 869

Countries citing papers authored by Nahed Baddour

Since Specialization
Citations

This map shows the geographic impact of Nahed Baddour's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Nahed Baddour with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Nahed Baddour more than expected).

Fields of papers citing papers by Nahed Baddour

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Nahed Baddour. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Nahed Baddour. The network helps show where Nahed Baddour may publish in the future.

Co-authorship network of co-authors of Nahed Baddour

This figure shows the co-authorship network connecting the top 25 collaborators of Nahed Baddour. A scholar is included among the top collaborators of Nahed Baddour based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Nahed Baddour. Nahed Baddour is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Baddour, Nahed, et al.. (2022). The classification of gastric antral vascular ectasia in cirrhotic patients by Versatile Intelligent Staining Technology. SHILAP Revista de lepidopterología. 12(1). 34–34. 1 indexed citations
2.
Baddour, Nahed, et al.. (2022). ARID1A expression in hepatocellular carcinoma and relation to tumor recurrence after microwave ablation. Clinical and Experimental Hepatology. 8(1). 49–59. 4 indexed citations
3.
Khalil, Ahmed, et al.. (2021). Does faecal calprotectin differentiate between inflammatory bowel disease colitis and non-inflammatory bowel disease colitides?. Gastroenterology Review. 16(3). 219–223. 4 indexed citations
4.
Baddour, Nahed, et al.. (2021). SQSTM1 Expression in Hepatocellular Carcinoma and Relation to Tumor Recurrence After Radiofrequency Ablation. Journal of Clinical and Experimental Hepatology. 12(3). 774–784. 6 indexed citations
5.
Baddour, Nahed, et al.. (2020). Predictors for hepatocellular carcinoma recurrence after microwave ablation. Clinical and Experimental Hepatology. 6(2). 77–84. 2 indexed citations
7.
Abu‐Serie, Marwa M., et al.. (2018). In vivo assessment of the hepatotoxicity of a new Nostoc isolate from the Nile River: Nostoc sp. strain NRI. Toxicon. 143. 81–89. 1 indexed citations
8.
Bekheit, Mohamed, et al.. (2016). Hyperbaric oxygen therapy stimulates colonic stem cells and induces mucosal healing in patients with refractory ulcerative colitis: a prospective case series. BMJ Open Gastroenterology. 3(1). e000082–e000082. 18 indexed citations
9.
Mansour, Ahmed, et al.. (2012). Schizophyllan inhibits the development of mammary and hepatic carcinomas induced by 7,12 dimethylbenz(α)anthracene and decreases cell proliferation: comparison with tamoxifen. Journal of Cancer Research and Clinical Oncology. 138(9). 1579–1596. 38 indexed citations
10.
Eissa, Maha M., et al.. (2012). Initial characterization of an autoclaved Toxoplasma vaccine in mice. Experimental Parasitology. 131(3). 310–316. 37 indexed citations
11.
Eissa, Maha M., Mervat Z. El‐Azzouni, Eglal I. Amer, & Nahed Baddour. (2010). Miltefosine, a promising novel agent for schistosomiasis mansoni. International Journal for Parasitology. 41(2). 235–242. 59 indexed citations
12.
Saudi, Manal N., et al.. (2010). Synthesis and biological evaluation of a novel class as antileishmanial agent. Medicinal Chemistry Research. 21(2). 257–267. 13 indexed citations
13.
Johnson, Timothy S., Nicholas J. Skill, Nahed Baddour, et al.. (2003). Tissue Transglutaminase and the Progression of Human Renal Scarring. Journal of the American Society of Nephrology. 14(8). 2052–2062. 96 indexed citations
14.
Baddour, Nahed, et al.. (2001). Role of stem cell factor and mast cells in the progression of chronic glomerulonephritides11See Editorial by Eddy, p. 375. Kidney International. 60(1). 167–172. 49 indexed citations
15.
Gavaler, J. S., et al.. (1994). Treatment of putative non-A, non-B, non-C hepatitis with alpha interferon: a preliminary trial.. PubMed. 87(8). 364–8. 5 indexed citations
16.
Thiel, David H. Van, et al.. (1994). Intrahepatic mononuclear cell populations and MHC antigen expression in patients with chronic hepatitis B: Effect of interferon-α. Digestive Diseases and Sciences. 39(5). 970–976. 17 indexed citations
17.
Thiel, David H. Van, Nahed Baddour, S. Fagiuoli, Harlan I. Wright, & Judith S. Gavaler. (1994). Alpha-interferon treatment of hepatitis C in patients with liver allografts treated with either FK-506 or cyclosporin A. European Journal of Gastroenterology & Hepatology. 6(9). 787–792. 3 indexed citations
18.
Máñez, Rafael, David J. Kramer, Harlan I. Wright, et al.. (1993). Liver Transplantation for Alcoholic Liver Disease: Survival of Patients Transplanted with Alcoholic Hepatitis Plus Cirrhosis as Compared with Those with Cirrhosis Alone. Alcoholism Clinical and Experimental Research. 17(5). 1102–1106. 34 indexed citations
19.
Kramer, David, et al.. (1993). Survival of patients transplanted with alcoholic hepatitis plus cirrhosis as compared with those with cirrhosis alone.. PubMed. 25(1 Pt 2). 1126–7. 2 indexed citations
20.
Abu‐Elmagd, Kareem, Richard W. Selby, Shunzaburo Iwatsuki, et al.. (1993). Cholangiocarcinoma and sclerosing cholangitis: clinical characteristics and effect on survival after liver transplantation.. PubMed. 25(1 Pt 2). 1124–5. 47 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026